Dr. Brian Moran: Brachytherapy: An Innovative Disruptor

Dr. Brian Moran, Medical Director for the Chicago Prostate Center, discusses the value of low-dose rate brachytherapy and its disruptive innovation in the cancer treatment field.

Dr. Moran stresses how important it is for clinicians to recognize the value of brachytherapy and promote it in order to carry it forward. Low-dose rate brachytherapy has been very threatening to other practice modalities in the past, yet it has endured through an environment in which it has only been promoted by the experts and community physicians who practice it.

Dr. Moran explains how brachytherapy has taken full advantage of today’s technology to bring patients the best care possible and the best results. “Many of the doctors have worked hard and we’ve learned as we’ve gone,” says Moran. And he is obviously excited about what the future holds.

My Question is Why?

My Question is Why?

By Dr. Ronald M. BenoitDepartment of Urology, University of Pittsburgh School of Medicine Why would a clinician be hesitant to use Cesium-131 to treat prostate cancer? I would venture to say the likely answer is the data that speaks to its benefits has not yet...

read more
Take Time to Think

Take Time to Think

By Dr. Bernard W. TaylorTexas Oncology - Longview Cancer Center The American Cancer Society’s 2022 Cancer Facts and Figures report estimates that nearly 270,000 men will be diagnosed with prostate cancer this year. This represents nearly 50% more than the number of...

read more
Looking Ahead

Looking Ahead

By CEO Lori Woods This is my first blog post, and it comes during a year that has changed how we communicate, how we work, and virtually every aspect of our lives. COVID-19 has challenged us and changed us. We hope for better days ahead even as we face the reality of...

read more